Navigation Links
Clostridium Infection Suspected In Abortion Deaths

U.S. health officials suspect the abortion pill, RU-486 to be associated with the outbreak of rare bacterial infections. //Out of the 6 women who took the pill 4 died of Clostridium infection. Mifeprex or RU-486 is now expected to be pulled from the shelves. Food and Drug Administration has not attributed their deaths to the drug. The rare bacterium infection is caused by Clostridium sordellii. The FDA concluded one of the six deaths was unrelated to the drug and another is still under review. Mifeprex, is manufactured by Danco Laboratories LLC, is taken along with a second drug called misoprostol early in pregnancy to trigger an abortion.

A panel of outside experts is thought to review related infections in tissue graft patients and outbreaks of Clostridium difficile bacteria infections in several states. A meeting is to be held regarding this issue which would identify the cause and further research in this subject. Dr. Vanessa Cullins, vice president for medical affairs at Planned Parenthood Federation of America, said that the meeting should not drift into politics but rather focus on science. But three anti-abortion groups have already filed a petition with the FDA in 2002 seeking its withdrawal. But the company says that about 575,000 women have taken Mifeprex since its approval and there is no evidence linking it to the deaths. But healthcare officials have expressed their concern over increasing bacterial infection become they are becoming more and more resistant to antibiotics.


'"/>




Page: 1

Related medicine news :

1. Patients With Filariasis More Prone To HIV Infection
2. Infection linked with heart attack
3. Link Between Infection And Heart Disease
4. Supplements for Ear Infections
5. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
6. Oral Medication Effective In Combating Eye Infection
7. The Effectiveness Of Antibacterial Products In Reducing Infection
8. Link Between Ear Infections And Asthma
9. Reducing The Rate Of Infections
10. Good News For Individuals Suffering From Frequent Throat Infections
11. Reducing The Rate Of Hospital Acquired Infections
Post Your Comments:
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2IPY follow up requires year round research on Arctic and global warming 9894 1Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 1Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 2Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 3Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 4Schofield Media Names Brian Reshefsky Group President 56972 1